Sonnet BioTherapeutics

Share on: 
Description: 

Sonnet BioTherapeutics is developing proprietary FHAB™ (Fully Human Albumin Binding) technology that empowers development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms.

Location(s): 
Princeton NJ
United States